A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome

Almudena Pérez-Rodríguez; Ana Batlle-López; Rosa Blanco; Ignacio Varela; Javier León; M. Dolores Delgado; Esther Lourés; Ángela Rodríguez-Trillo; Aránzazu García-Rivero; Joana Costa-Pinto; Javier Batlle; María Fernanda López-Fernández

doi:10.1160/th14-02-0116

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 112(05): 1065-1068
DOI: 10.1160/th14-02-0116

Letters to the Editor

Schattauer GmbH

A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome

Authors

Almudena Pérez-Rodríguez

¹Servicio de Hematología y Hemoterapia, Complexo Hospitalario Universitario A Coruña, A Coruña, Department of Medicine, School of Medicine, University of Santiago de Compostela, Spain
Ana Batlle-López

²Servicio de Hematología y Hemoterapia, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain

³Departamento de Biología Molecular e Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria, CSIC, SODERCAN, Santander, Spain
Rosa Blanco

³Departamento de Biología Molecular e Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria, CSIC, SODERCAN, Santander, Spain
Ignacio Varela

³Departamento de Biología Molecular e Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria, CSIC, SODERCAN, Santander, Spain
Javier León

³Departamento de Biología Molecular e Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria, CSIC, SODERCAN, Santander, Spain
M. Dolores Delgado

³Departamento de Biología Molecular e Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria, CSIC, SODERCAN, Santander, Spain
Esther Lourés

¹Servicio de Hematología y Hemoterapia, Complexo Hospitalario Universitario A Coruña, A Coruña, Department of Medicine, School of Medicine, University of Santiago de Compostela, Spain
Ángela Rodríguez-Trillo

¹Servicio de Hematología y Hemoterapia, Complexo Hospitalario Universitario A Coruña, A Coruña, Department of Medicine, School of Medicine, University of Santiago de Compostela, Spain
Aránzazu García-Rivero

⁴Centro Oncológico de Galicia, A Coruña, Spain
Joana Costa-Pinto

¹Servicio de Hematología y Hemoterapia, Complexo Hospitalario Universitario A Coruña, A Coruña, Department of Medicine, School of Medicine, University of Santiago de Compostela, Spain
Javier Batlle

¹Servicio de Hematología y Hemoterapia, Complexo Hospitalario Universitario A Coruña, A Coruña, Department of Medicine, School of Medicine, University of Santiago de Compostela, Spain
María Fernanda López-Fernández

¹Servicio de Hematología y Hemoterapia, Complexo Hospitalario Universitario A Coruña, A Coruña, Department of Medicine, School of Medicine, University of Santiago de Compostela, Spain

Abstract

Full Text

References

References
1 Levy GG, Nichols WC, Lian EC. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.. Nature 2001; 413: 488-494.
2 Kokame K, Matsumoto M, Soejima K. et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.. Proc Natl Acad Sci USA 2002; 99: 11902-11907.
3 Uchida T, Wada H, Mizutani M. et al. Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura.. Blood 2004; 104: 2081-2083.
4 Furlan M, Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.. Best Pract Res Clin Haematol 2001; 14: 437-454.
5 Lotta LA, Wu HM, Mackie IJ. et al. Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.. Blood 2012; 120: 440-448.
6 Veyradier A, Obert B, Haddad E. et al. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome.. J Pediatr 2003; 142: 310-317.
7 Kremer Hovinga JA, Studt JD, Lämmle B. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).. Pathophysiol Haemost Thromb 2003; 33: 417-421.
8 Schneppenheim R, Budde U, Oyen F. et al. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.. Blood 2003; 101: 1845-1850.
9 Park HW, Oh D, Kim N. et al. Congenital thrombotic thrombocytopenic purpura associated with unilateral moyamoya disease.. Pediatr Nephrol 2008; 23: 1555-1558.
10 Mise K, Ubara Y, Matsumoto M. et al. Long term follow up of congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) on hemodialysis for 19 years: a case report.. BMC Nephrol 2013; 14: 156.
11 Antoine G, Zimmermann K, Plaimauer B. et al. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.. Br J Haematol 2003; 120: 821-824.
12 Garagiola I, Valsecchi C, Lavoretano S. et al. Nonsense-mediated mRNA decay in the ADAMTS13 gene caused by a 29-nucleotide deletion.. Haematologica 2008; 93: 1678-1685.
13 Zhang P, Pan W, Rux AH. et al. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.. Blood 2007; 110: 1887-1894.
14 Donadelli R, Banterla F, Galbusera M. et al. Invitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura.. Thromb Haemost 2006; 96: 454-464.
15 Fujimura Y, Matsumoto M, Kokame K. et al. Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients.. Br J Haematol 2009; 144: 742-754.
16 Palla R, Lavoretano S, Lombardi R. et al. The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura.. Haematologica 2009; 94: 289-293.